Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30,210,911
-
Total 13F shares
-
2,647,726
-
Share change
-
+2,647,726
-
Total reported value
-
$24,413,000
-
Price per share
-
$9.22
-
Number of holders
-
16
-
Value change
-
+$24,413,000
-
Number of buys
-
16
Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q3 2016
As of 30 Sep 2016,
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,647,726 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, PUTNAM INVESTMENTS LLC, Monashee Investment Management LLC, Alyeska Investment Group, L.P., BAKER BROS. ADVISORS LP, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., Nationwide Fund Advisors, and Laurion Capital Management LP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.